Dublin, Sept. 14, 2021 (GLOBE NEWSWIRE) -- The "Scar Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
The global scar treatment market exhibited moderate growth during 2015-2020. Scar treatment refers to the techniques and procedures employed for the remedy of acne, keloid, contracture, hypertrophic scars, etc. Scars are visible wound marks caused by surgeries, injuries or infections. The treatment and revision procedures are employed to minimize the appearance of these scars so that they look more consistent with the surrounding skin tone and texture. In order to speed up the healing process, various treatments are used, including over the counter (OTC) gels, ointments, creams, silicone sheets; surgeries for skin grafts, excisions or laser treatment; and collagen injections. In some cases, topical creams enriched with Vitamin E are also applied to diminish post-surgery scars.
The increasing prevalence of skin diseases, along with the rising consumer awareness regarding various scar treatment options, represent as the key factors driving the growth of the market. The growing aesthetic sense among the masses has led to the widespread adoption of skin treatment procedures. Furthermore, enhanced accessibility to dermatological facilities and the introduction of products containing both chemical and herbal ingredients are boosting the overall demand for the service. Dermatological clinics offer precise and latest technological procedures for cosmetic surgeries that provide effective results and cause minimal discomfort to the patient.
Additionally, surgeries conducted using laser instruments are used for reducing the visibility of scars after critical injuries. These surgeries also speed up the healing process while ensuring a painless experience for the patient. Other factors, such as rising urbanization, inflating disposable incomes and the increase in affluent population, aggressive promotional activities by service providers and the introduction of organic and natural products, are projected to drive the market in the upcoming years. Looking forward, the publisher expects the global scar treatment market to grow at a CAGR of 8.2% during the forecast period (2021-2026).
Breakup by Product or Treatment Type:
- Topical Products
- Gels
- Creams
- Oils
- Sheets
- Laser Treatment
- Surface Treatment
- Injectables
Breakup by Scar Type:
- Atrophic Scars
- Hypertrophic and Keloid Scars
- Contracture Scars
- Others
Breakup by End-User:
- Hospitals
- Clinics
- Retail Pharmacies
- Others
Breakup by Region:
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- North America
- United States
- Canada
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Latin America
- Brazil
- Mexico
- Argentina
- Columbia
- Chile
- Peru
- Middle East and Africa
- Turkey
- Saudi Arabia
- Iran
- United Arab Emirates
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Alliance Pharma, Avita Medical, Bausch Health, Cutera Inc., Establishment Labs S.A., GC Aesthetics PLC, Hologic Inc., Molnlycke Health Care, Smith & Nephew, Sonoma Pharmaceuticals, etc.
Key Questions Answered in This Report:
- How has the global scar treatment market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global scar treatment market?
- What is the breakup of the market based on the product or treatment type?
- What is the breakup of the market based on the scar type?
- What is the breakup of the market based on the end-user?
- What are the key driving factors and challenges in the market?
- What is the structure of the global scar treatment market and who are the key players?
- What is the degree of competition in the market?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Scar Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product or Treatment Type
6.1 Topical Products
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Gels
6.1.2.2 Creams
6.1.2.3 Oils
6.1.2.4 Sheets
6.1.2.5 Others
6.1.3 Market Forecast
6.2 Laser Treatment
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Surface Treatment
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Injectables
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Scar Type
7.1 Atrophic Scars
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Hypertrophic and Keloid Scars
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Contracture Scars
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by End-User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Retail Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
10 SWOT Analysis
11 Value Chain Analysis
12 Porters Five Forces Analysis
13 Price Indicators
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Alliance Pharma
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Avita Medical
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 Bausch Health
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Cutera Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Establishment Labs S.A.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 GC Aesthetics PLC
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Hologic Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Molnlycke Health Care
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Smith & Nephew
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Sonoma Pharmaceuticals
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
For more information about this report visit https://www.researchandmarkets.com/r/66r63z
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
